WO2001068841A3 - Human dcc-like proteins - Google Patents
Human dcc-like proteins Download PDFInfo
- Publication number
- WO2001068841A3 WO2001068841A3 PCT/EP2001/002784 EP0102784W WO0168841A3 WO 2001068841 A3 WO2001068841 A3 WO 2001068841A3 EP 0102784 W EP0102784 W EP 0102784W WO 0168841 A3 WO0168841 A3 WO 0168841A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- dcc
- regulate
- human
- human dcc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Reagents which regulate human Deleted in Colon Cancer (DCC)-like protein activity can be used to regulate axon outgrowth. Such regulation is particularly useful for modulating neuronal growth regenerative capacity, i.e. the regeneration of axons in adult nervous system after, for example, injury or trauma, for diagnosing genetic neurological defects, and for treating neurodegenerative disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2001260116A AU2001260116A1 (en) | 2000-03-14 | 2001-03-13 | Human dcc-like proteins |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18908700P | 2000-03-14 | 2000-03-14 | |
| US60/189,087 | 2000-03-14 | ||
| US25488000P | 2000-12-13 | 2000-12-13 | |
| US60/254,880 | 2000-12-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001068841A2 WO2001068841A2 (en) | 2001-09-20 |
| WO2001068841A3 true WO2001068841A3 (en) | 2003-01-09 |
Family
ID=26884765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2001/002784 Ceased WO2001068841A2 (en) | 2000-03-14 | 2001-03-13 | Human dcc-like proteins |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001260116A1 (en) |
| WO (1) | WO2001068841A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120310800B (en) * | 2025-06-17 | 2025-09-30 | 中国科学院深圳先进技术研究院 | Promoter, recombinant vector, adeno-associated virus and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991009964A1 (en) * | 1990-01-04 | 1991-07-11 | The Johns Hopkins University | Gene deleted in colorectal cancer of humans |
| WO1997014424A1 (en) * | 1995-10-16 | 1997-04-24 | The Regents Of The University Of California | Neurological drug screens |
-
2001
- 2001-03-13 WO PCT/EP2001/002784 patent/WO2001068841A2/en not_active Ceased
- 2001-03-13 AU AU2001260116A patent/AU2001260116A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991009964A1 (en) * | 1990-01-04 | 1991-07-11 | The Johns Hopkins University | Gene deleted in colorectal cancer of humans |
| WO1997014424A1 (en) * | 1995-10-16 | 1997-04-24 | The Regents Of The University Of California | Neurological drug screens |
Non-Patent Citations (6)
| Title |
|---|
| DATABASE EMBL [online] 14 February 2000 (2000-02-14), SULSTON J.E. ET AL.: "Homo sapiens BAC clone RP11-88L24 from 2, complete sequence.", XP002217056, retrieved from EBI Database accession no. AC023270 * |
| DATABASE EMBL [online] 18 June 1998 (1998-06-18), ROBERT STRAUSBERG: "ot34c11.s1 Soares_testis_NHT Homo sapiens cDNA clone IMAGE:1618676 3', mRNA sequence", XP002217054, retrieved from EBI Database accession no. AI015495 * |
| DATABASE EMBL [online] 19 January 1998 (1998-01-19), ROBERT STRAUSBERG: "nx62b11.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:1266813, mRNA sequence", XP002217058, retrieved from EBI Database accession no. AA746678 * |
| DATABASE EMBL [online] 23 November 1998 (1998-11-23), ROBERT STRAUSBERG: "ql58h01.x1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:1876561 3' similar to SW:VEGR_RAT P53767 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1", XP002217055, retrieved from EBI Database accession no. AI274972 * |
| DATABASE EMBL [online] 29 July 1996 (1996-07-29), NAKAMURA Y. ET AL.: "Human Heart cDNA, clone 3NHC3304.", XP002217057, retrieved from EBI Database accession no. C04411 * |
| KEINO-MASU K ET AL: "DELETED IN COLORECTAL CANCER (DCC) ENCODES A NETRIN RECEPTOR", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 87, no. 2, 18 October 1996 (1996-10-18), pages 175 - 185, XP000941995, ISSN: 0092-8674 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001260116A1 (en) | 2001-09-24 |
| WO2001068841A2 (en) | 2001-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE256475T1 (en) | USE OF FOLLISTATIN IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF MUSCLE DISEASES | |
| EP0554383A4 (en) | ||
| IL124728A0 (en) | Diagnosis and treatment of aur-1 and/or aur-2 related disorders | |
| CA2174971A1 (en) | Neural Axon Outgrowth Modulators | |
| CA2232789A1 (en) | Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product | |
| ATE346303T1 (en) | METHODS FOR DIAGNOSIS, PRODUCTION OF MEDICATIONS AND SCREENING OF SUBSTANCES AS WELL AS BETA-AMYLOID DERIVED PEPTIDES ASSOCIATED WITH ALZHEIMER'S DISEASE | |
| EP1361229A3 (en) | Use of Tyrosine Kinase (PYK2) to produce antibodies | |
| WO1997004097A3 (en) | Human CTLA-8 and uses of CTLA-8-related proteins | |
| DE3855921D1 (en) | Process and deoxyribonucleic acid for the production of tissue factor protein | |
| EP1420031A3 (en) | Bone morphogenetic protein (BMP)-18 compositions | |
| WO2001066596A3 (en) | Human fgf-23 gene and gene expression products | |
| AU2742892A (en) | An anticoagulant substance obtained from urine | |
| WO1998026054A3 (en) | Pyk2 related products and methods | |
| ATE259652T1 (en) | NEURAL USES OF THE BMP-11 | |
| Perry et al. | Olfactory neural cells: an untapped diagnostic and therapeutic resource | |
| WO1997023611A3 (en) | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof | |
| Schwalb et al. | Optic nerve glia secrete a low-molecular-weight factor that stimulates retinal ganglion cells to regenerate axons in goldfish | |
| WO2001068841A3 (en) | Human dcc-like proteins | |
| DE3751249D1 (en) | Protein L and its subunits, with immunoglobulin binding activity, method of preparation, reagent kit, pharmaceutical preparation and a Peptococcus magnus strain. | |
| WO1997035976A3 (en) | Epidermal differentiation factor | |
| DiStefano et al. | Regulation of Schwann cell surface and truncated nerve growth factor receptors in vitro by axonal components | |
| AU5659798A (en) | Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury | |
| PT990000E (en) | CONJUNCTIVE TISSUE GROWTH FACTOR 3 | |
| AUPN674895A0 (en) | Synthetic mammalian alpha-N-acetylglucosaminidase and genetic sequences encoding same | |
| AU4654097A (en) | Rdgb-proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |